Carregant...
Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
The potential for immunogenicity is an ever-present concern during the development of biopharmaceuticals. Therapeutic antibodies occasionally elicit an antibody response in patients, which can result in loss of response or adverse effects. However, antibodies that bind a drug are sometimes found in...
Guardat en:
| Publicat a: | MAbs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623040/ https://ncbi.nlm.nih.gov/pubmed/25962087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1048411 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|